Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net income (loss)	$ (23,168)	$ (3,605)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	171,722	168,211
Amortization of capitalized software developed for sale	1,302	717
Accretion and changes in estimate, net	4,800	4,732
Equity compensation	49,961	26,166
Deferred income tax expense (benefit)	(10,411)	(8,989)
Amortization of debt discount and issuance costs	7,770	7,910
Loss on extinguishment of debt	390
Non-cash lease expense	5,681	7,007
Other, net	3,916	249
Changes in operating assets and liabilities:
Accounts receivable, net	1,991	(11,773)
Contract assets, net	30,028	(3,090)
Prepaid expenses and other assets	(20,811)	(25,029)
Accounts payable	(2,481)	34,722
Accrued expenses and other liabilities	(75,394)	(53,649)
Deferred revenue	(61,981)	(33,472)
Net cash provided by (used in) operating activities	83,315	110,107
Cash flows from investing activities:
Capitalized expenditures	(79,535)	(66,006)
Other, net		(1,000)
Net cash provided by (used in) investing activities	(79,535)	(67,006)
Cash flows from financing activities:
Payments on Senior Notes	(100,000)
Payments under tax receivable agreements	(48,462)	(21,537)
Receipts (payments) on derivative instruments	(410)	(7,364)
Employee tax withholding on vesting of equity compensation awards	(6,407)	(13,015)
Payments on deferred financing obligations	(2,331)	(6,796)
Payment of senior amortizing notes	(4,254)	(3,965)
Proceeds from exercise of equity awards	1,274	5,225
Other, net	(58)	(116)
Net cash provided by (used in) financing activities	(160,648)	(47,568)
Effect of exchange rate changes on cash and cash equivalents	(1,421)	470
Net increase (decrease) in cash and cash equivalents	(158,289)	(3,997)
Cash and cash equivalents at beginning of period	252,298	113,101
Cash and cash equivalents at end of period	$ 94,009	$ 109,104